Otivio's Angel Round

Otivio raised a round of funding on January 02, 2016.

Otivio's core technology enables increased blood flow to the limbs of a patient. Otivio's main product, FlowOx, is addressing peripheral arterial disease (PAD), which is a serious condition leading to…

Articles about Otivio's Angel Round: